laparoscopic right adrenalectomy
Procedureadrenalectomy
NCT Number: NCT06330558
Context: Adrenalectomy for pheochromocytoma (PHEO) poses difficulties due to the elevated chance of conversion. The objective of this study was to conduct a comparative analysis of the occurrence and determinants of conversion in left-sided abdominal laparoscopic adrenalectomy (LLA) and right-sided abdominal laparoscopic adrenalectomy (RLA).
Methods: A retrospective analysis was conducted to include a total of 271 patients diagnosed with PHEO. These patients were separated into two groups: LRA (N=121) and LLA (N=150). The study period spanned from September 2016 to September 2023.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
The process of performing an adrenalectomy for pheochromocytoma (PHEO) is difficult due to the significant risk of conversion. The objective of this study was to conduct a comparative analysis of the occurrence and determinants of conversion in left-sided abdominal laparoscopic adrenalectomy (LLA) and right-sided abdominal laparoscopic adrenalectomy (RLA).
Methods: A retrospective analysis was conducted to include a total of 271 patients diagnosed with PHEO. These patients were separated into two groups: LRA (N=121) and LLA (N=150). The study period spanned from September 2016 to September 2023.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Bilateral PHEOS. Hemorrhagic diathesis, Structural deformity Pregnancy,
adrenalectomy
Time frame: intraoperative
number of conversion
Zagazig University
Other Gov
Side-specific Factors for Conversion in Adrenalectomy for Pheochromocytoma. A Comparative Analysis
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04804163
Adenocarcinoma, Adrenal Gland Diseases
Qingdao, Shandong, China
View Trial DetailsNCT04570176
Adenocarcinoma, Adrenal Gland Diseases
Qingdao, Shandong, China
View Trial DetailsNCT03830593
ACTH Syndrome, Ectopic, Adrenal Adenoma
Samsun, Turkey (Türkiye)
View Trial DetailsNCT04071561
Adrenal Cortex Diseases, Adrenal Cortex Neoplasms
Basel, Switzerland
View Trial Details